Cargando…

Summary of AHRQ's Comparative Effectiveness Review of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers Added to Standard Medical Therapy for Treating Stable Ischemic Heart Disease

Detalles Bibliográficos
Autores principales: White, Michael, Greene, Laurence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438269/
https://www.ncbi.nlm.nih.gov/pubmed/21780334
http://dx.doi.org/10.18553/jmcp.2011.17.s5.1
_version_ 1785092753262116864
author White, Michael
Greene, Laurence
author_facet White, Michael
Greene, Laurence
author_sort White, Michael
collection PubMed
description
format Online
Article
Text
id pubmed-10438269
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Academy of Managed Care Pharmacy
record_format MEDLINE/PubMed
spelling pubmed-104382692023-08-21 Summary of AHRQ's Comparative Effectiveness Review of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers Added to Standard Medical Therapy for Treating Stable Ischemic Heart Disease White, Michael Greene, Laurence J Manag Care Pharm Supplement Academy of Managed Care Pharmacy 2011-06 /pmc/articles/PMC10438269/ /pubmed/21780334 http://dx.doi.org/10.18553/jmcp.2011.17.s5.1 Text en Copyright © 2011, Academy of Managed Care Pharmacy. All rights reserved. https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Supplement
White, Michael
Greene, Laurence
Summary of AHRQ's Comparative Effectiveness Review of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers Added to Standard Medical Therapy for Treating Stable Ischemic Heart Disease
title Summary of AHRQ's Comparative Effectiveness Review of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers Added to Standard Medical Therapy for Treating Stable Ischemic Heart Disease
title_full Summary of AHRQ's Comparative Effectiveness Review of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers Added to Standard Medical Therapy for Treating Stable Ischemic Heart Disease
title_fullStr Summary of AHRQ's Comparative Effectiveness Review of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers Added to Standard Medical Therapy for Treating Stable Ischemic Heart Disease
title_full_unstemmed Summary of AHRQ's Comparative Effectiveness Review of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers Added to Standard Medical Therapy for Treating Stable Ischemic Heart Disease
title_short Summary of AHRQ's Comparative Effectiveness Review of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers Added to Standard Medical Therapy for Treating Stable Ischemic Heart Disease
title_sort summary of ahrq's comparative effectiveness review of angiotensin-converting enzyme inhibitors or angiotensin ii receptor blockers added to standard medical therapy for treating stable ischemic heart disease
topic Supplement
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438269/
https://www.ncbi.nlm.nih.gov/pubmed/21780334
http://dx.doi.org/10.18553/jmcp.2011.17.s5.1
work_keys_str_mv AT whitemichael summaryofahrqscomparativeeffectivenessreviewofangiotensinconvertingenzymeinhibitorsorangiotensiniireceptorblockersaddedtostandardmedicaltherapyfortreatingstableischemicheartdisease
AT greenelaurence summaryofahrqscomparativeeffectivenessreviewofangiotensinconvertingenzymeinhibitorsorangiotensiniireceptorblockersaddedtostandardmedicaltherapyfortreatingstableischemicheartdisease